Cidara Therapeutics Inc (CDTX)
17.45
+2.33
(+15.41%)
USD |
NASDAQ |
Nov 21, 16:00
17.23
-0.22
(-1.26%)
After-Hours: 20:00
Cidara Therapeutics Price: 17.45 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 18.98 | 19.98 | 17.17 | 17.45 | 450940.0 |
| Nov 20, 2024 | 15.68 | 16.64 | 15.02 | 15.12 | 45617.00 |
| Nov 19, 2024 | 14.93 | 15.63 | 14.93 | 15.63 | 14825.00 |
| Nov 18, 2024 | 14.33 | 14.99 | 14.33 | 14.96 | 47783.00 |
| Nov 15, 2024 | 14.50 | 14.97 | 13.90 | 14.37 | 31566.00 |
| Nov 14, 2024 | 14.08 | 14.75 | 13.82 | 14.48 | 30025.00 |
| Nov 13, 2024 | 13.31 | 14.00 | 13.27 | 13.90 | 27119.00 |
| Nov 12, 2024 | 13.58 | 13.73 | 13.14 | 13.45 | 19359.00 |
| Nov 11, 2024 | 13.51 | 13.68 | 12.89 | 13.35 | 10773.00 |
| Nov 08, 2024 | 13.28 | 13.78 | 13.03 | 13.50 | 23505.00 |
| Nov 07, 2024 | 12.91 | 13.40 | 12.74 | 13.11 | 31689.00 |
| Nov 06, 2024 | 13.47 | 13.47 | 12.78 | 13.26 | 10430.00 |
| Nov 05, 2024 | 13.03 | 13.26 | 13.00 | 13.26 | 14219.00 |
| Nov 04, 2024 | 13.09 | 13.45 | 13.00 | 13.03 | 20154.00 |
| Nov 01, 2024 | 12.85 | 13.13 | 12.66 | 13.09 | 10602.00 |
| Oct 31, 2024 | 12.77 | 13.00 | 12.70 | 13.00 | 5620.00 |
| Oct 30, 2024 | 13.39 | 13.39 | 12.65 | 12.83 | 28116.00 |
| Oct 29, 2024 | 12.61 | 13.92 | 12.54 | 13.39 | 25478.00 |
| Oct 28, 2024 | 12.92 | 12.92 | 12.10 | 12.47 | 8427.00 |
| Oct 25, 2024 | 11.30 | 13.25 | 11.28 | 12.60 | 74991.00 |
| Oct 24, 2024 | 11.40 | 11.70 | 11.12 | 11.16 | 10838.00 |
| Oct 23, 2024 | 11.11 | 11.41 | 11.07 | 11.30 | 18444.00 |
| Oct 22, 2024 | 11.09 | 11.39 | 11.09 | 11.38 | 3019.00 |
| Oct 21, 2024 | 11.49 | 11.49 | 11.07 | 11.22 | 16728.00 |
| Oct 18, 2024 | 11.01 | 11.58 | 10.37 | 11.26 | 42879.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.56
Minimum
May 13 2022
85.20
Maximum
Jan 27 2020
30.88
Average
22.60
Median
Apr 18 2023
Price Benchmarks
| Biomarin Pharmaceutical Inc | 63.45 |
| Arbutus Biopharma Corp | 3.46 |
| GlycoMimetics Inc | 0.32 |
| FibroGen Inc | 0.3872 |
| Cue Biopharma Inc | 1.03 |
Price Related Metrics
| PS Ratio | 1.433 |
| PEG Ratio | -0.0009 |
| Price to Book Value | 1.063 |
| Earnings Yield | -145.3% |
| Market Cap | 122.96M |
| PEGY Ratio | -0.0009 |